Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Poston

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
Gut|November 5, 2011
Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)John K Ramage, A Ahmed, J Ardill, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 24, 2025
Central TYK2 inhibition identifies TYK2 as a key neuroimmune modulatorTyler P Molitor, Genki Hayashi, Mei-Yao Lin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 13, 2014
Still a long way to go to achieve multidisciplinarity for the benefit of patients: commentary on the ESMO position paper (Annals of Oncology 25(1): 9-15, 2014)V Valentini, P-A Abrahamsson, S K Aranda, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
Gut|November 5, 2011
Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)John K Ramage, A Ahmed, J Ardill, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 24, 2025
Central TYK2 inhibition identifies TYK2 as a key neuroimmune modulatorTyler P Molitor, Genki Hayashi, Mei-Yao Lin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 13, 2014
Still a long way to go to achieve multidisciplinarity for the benefit of patients: commentary on the ESMO position paper (Annals of Oncology 25(1): 9-15, 2014)V Valentini, P-A Abrahamsson, S K Aranda, et al.
Pageof 5